Skip to main content

Articles

Practice Management
Employers, Health Plans, and New Drug Benefit Designs: A Shifting Landscape
Read More
Graft-versus-Host Disease Often Leads to Posttransplant Readmission, High Costs
Read More
Is Plerixafor Cost-Effective for Stem-Cell Mobilization?
Read More
Leukemia, Oncology
Bosutinib Shows Superior Results in CML
Read More
Leukemia, Oncology
Novel Oral B-Cell Receptor Inhibitor Very Effective in Chronic Lymphocytic Leukemia
Read More
Multiple Myeloma, Multiple Myeloma, Oncology
VISTA Final Analysis Upholds Survival Benefit of Bortezomib at 5 Years
Read More
Multiple Myeloma, Multiple Myeloma, Oncology
Maintenance Strategies in Elderly Patients with Myeloma Not Eligible for Transplant
Read More
Guidelines for Molecular/Cytogenetic Tests Can Eliminate Overordering, Reduce Costs
Read More
Conference Highlights ASH
Ready-Made Platelets? A Boon for Patients If It Works
Read More
Cost of Treating Myeloproliferative Neoplasms Is Significant
Read More
Page 207 of 244
Results 2061 - 2070 of 2439